Clinical trial
Intra-arterial Microplasmin Administration in Patients With Acute Peripheral…
NCT00123292 · ThromboGenics, Industry · Terminated
Key facts
| NCT number | NCT00123292 |
|---|---|
| Title | Intra-arterial Microplasmin Administration in Patients With Acute Peripheral Arterial Occlusion |
| Official title | An Open-label, Ascending-dose, Clinical Trial of Intra-arterial Microplasmin Administration in Patients With Acute Peripheral Arterial Occlusion |
| Lead sponsor | ThromboGenics, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Arterial Occlusive Diseases |
| Intervention type | Drug |
| Interventions | Microplasmin |
| Enrollment | 19 |
| Start date | Mar 1, 2005 |
| Primary completion | Jun 1, 2007 |
| Completion | Nov 1, 2009 |
| First posted | Jul 22, 2005 |
| Last update posted | Apr 7, 2014 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: